CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2017; 75(06): 345-348
DOI: 10.1590/0004-282X20170063
ARTICLE

Is there a relationship between narcolepsy, multiple sclerosis and HLA-DQB1*06:02?

Existe relação entre narcolepsia, esclerose múltipla e HLA-DQB1*06:02?
Paulo José Lorenzoni
1   Universidade Federal do Paraná, Hospital de Clínicas, Departamento de Medicina Interna, Serviço de Neurologia, Curitiba PR, Brasil.
,
Lineu Cesar Werneck
1   Universidade Federal do Paraná, Hospital de Clínicas, Departamento de Medicina Interna, Serviço de Neurologia, Curitiba PR, Brasil.
,
Ana Christina de Souza Crippa
1   Universidade Federal do Paraná, Hospital de Clínicas, Departamento de Medicina Interna, Serviço de Neurologia, Curitiba PR, Brasil.
,
Alessandra Zanatta
1   Universidade Federal do Paraná, Hospital de Clínicas, Departamento de Medicina Interna, Serviço de Neurologia, Curitiba PR, Brasil.
,
Cláudia S. Kamoi Kay
1   Universidade Federal do Paraná, Hospital de Clínicas, Departamento de Medicina Interna, Serviço de Neurologia, Curitiba PR, Brasil.
,
Carlos Eduardo S. Silvado
1   Universidade Federal do Paraná, Hospital de Clínicas, Departamento de Medicina Interna, Serviço de Neurologia, Curitiba PR, Brasil.
,
Rosana Herminia Scola
1   Universidade Federal do Paraná, Hospital de Clínicas, Departamento de Medicina Interna, Serviço de Neurologia, Curitiba PR, Brasil.
› Author Affiliations

ABSTRACT

We studied multiple sclerosis (MS) patients with the HLA-DQB1*06:02 allele and compared them with MS patients who did not carry the HLA-DQB1*06:02 allele. We analyzed clinical and neurophysiological criteria for narcolepsy in six MS patients with HLA-DQB1*06:02, compared with 12 MS patients who were HLA-DQB1*06:02 non-carriers. Only two patients with HLA-DQB1*06:02 allele scored higher than 10 on the Epworth Sleepiness Scale. Polysomnography recording parameters and the multiple sleep latency test showed an absence of narcolepsy in the study group. Our study suggested no significant correlation between narcolepsy, MS and HLA-DQB1*06:02. The HLA-DQB1*06:02 allele alone was not sufficient to cause MS patients to develop narcolepsy.

RESUMO

Pacientes com esclerose múltipla (EM) portadores do alelo HLA-DQB1*06:02 foram estudados e comparados com pacientes com EM mas que não são portadores do alelo HLA-DQB1*06:02. Os critérios clínicos e neurofisiológicos para narcolepsia foram analisados em pacientes com EM sendo 6 pacientes com o HLA-DQB1*06:02 comparados a 12 pacientes sem o HLA-DQB1*06:02. Somente 2 pacientes com EM e HLA-DQB1*06:02 tiveram escore maior que 10 na escala “Epworth Sleepiness Scale”. Os parâmetros da polissonografia e o teste de múltiplas latências do sono mostraram ausência de narcolepsia no grupo estudo. Nosso estudo não sugere correlações significantes entre narcolepsia, EM e HLA-DQB1*06:02. Somente o HLA-DQB1*06:02 não foi suficiente para desenvolver narcolepsia em pacientes com EM.

Support:

This study was supported by Fundação Araucária, CAPES and CNPq.




Publication History

Received: 16 May 2016

Accepted: 14 March 2017

Article published online:
05 September 2023

© 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Alóe F, Alves RC, Araújo JF, Azevedo A, Bacelar A, Bezerra M et al. [Brazilian guidelines for the diagnosis of narcolepsy]. Rev Bras Psiquiatr. 2010;32(3):294-304. Portuguese. http://dx.doi.org/10.1590/S1516-44462010005000014
  • 2 Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev. 2005;9(4):269-310. https://doi.org/10.1016/j.smrv.2005.03.004
  • 3 Mahlios J, De la Herrán-Arita AK, Mignot E. The autoimmune basis of narcolepsy. Curr Opin Neurobiol. 2013;23(5):767-73. https://doi.org/10.1016/j.conb.2013.04.013
  • 4 Veauthier C. Sleep disorders in multiple sclerosis: review. Curr Neurol Neurosci Rep. 2015;15(5):21. https://doi.org/10.1007/s11910-015-0546-0
  • 5 Vrethem M, Malmgren K, Lindh J. A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination. J Neurol Sci. 2012;321(1-2):89-91. https://doi.org/10.1016/j.jns.2012.07.025
  • 6 Vetrugno R, Stecchi S, Plazzi G, Lodi R, D’Angelo R, Alessandria M et al. Narcolepsy-like syndrome in multiple sclerosis. Sleep Med. 2009;10(3):389-91. https://doi.org/10.1016/j.sleep.2008.03.009
  • 7 American Academy of Sleep Medicine. International classification of sleep disorders, 3rd ed: diagnostic and coding manual. Darien: American Academy of Sleep Medicine; 2014.
  • 8 Poirier G, Montplaisir J, Dumont M, Duquette P, Décary F, Pleines J et al. Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology. 1987;37(4):693-5. https://doi.org/10.1212/WNL.37.4.693
  • 9 Marrie RA, Reider N, Cohen J, Trojano M, Sorensen PS, Cutter G et al. A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis. Mult Scler. 2015;21(3):342-9. https://doi.org/10.1177/1352458514564486
  • 10 Peraita-Adrados R, Lammers GJ, De Andrés C, Santamaría J, Vicario JL, Tafti M. A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms? Sleep Med. 2013;14(7):695-6. https://doi.org/10.1016/j.sleep.2013.03.015